Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Heron Therapeutics (HRTX) Interest & Investment Income (2016)

Historic Interest & Investment Income for Heron Therapeutics (HRTX) over the last 5 years, with Q4 2016 value amounting to $1.1 million.

  • Heron Therapeutics' Interest & Investment Income changed N/A to $1.1 million in Q4 2016 from the same period last year, while for Dec 2016 it was $445000.0, marking a year-over-year change of. This contributed to the annual value of $3.6 million for FY2024, which is 552.91% up from last year.
  • Heron Therapeutics' Interest & Investment Income amounted to $1.1 million in Q4 2016.
  • Heron Therapeutics' Interest & Investment Income's 5-year high stood at $1.1 million during Q4 2016, with a 5-year trough of -$209000.0 in Q3 2013.
  • Moreover, its 3-year median value for Interest & Investment Income was -$196000.0 (2012), whereas its average is -$19250.0.
  • Examining YoY changes over the last 5 years, Heron Therapeutics' Interest & Investment Income showed a top increase of 4448.67% in 2012 and a maximum decrease of 600000.0% in 2012.
  • Quarter analysis of 3 years shows Heron Therapeutics' Interest & Investment Income stood at -$197000.0 in 2012, then fell by 6.09% to -$209000.0 in 2013, then skyrocketed by 606.7% to $1.1 million in 2016.
  • Its Interest & Investment Income stands at $1.1 million for Q4 2016, versus -$209000.0 for Q3 2013 and -$204000.0 for Q2 2013.